Abstract

Several analogs of 5-hydroxy-2-formylpyridine thiosemicarbazone (5-HP) that contain isosteric replacement of sulfur by Se, NH or O have been synthesized. Measurement of the antineoplastic activity of these compounds in mice bearing Sarcoma 180 ascites cells indicated that 5-HP was the most active of these agents; the seleno analog was intermediate in potency, and the guanylhydrazone and semicarbazone were inactive against this tumor. 5-HP and its seleno analog both caused marked inhibition of DNA synthesis in vitro, as measured by the incorporation of thymidine-methyl- 3H, 5- 3H-cytidine or adenine-8- 14C into DNA. The syntheses of RNA and protein were relatively unaffected by these agents under the conditions employed. None of the compounds prevented the incorporation of 5- 3H-cytidine into acid-soluble pyrimidine ribonucleotides, but 5-HP and its selenosemicarbazone markedly depressed the subsequent progression of radioactivity into pyrimidine deoxyribonucleotide pools, suggesting that these two derivatives inhibited the enzyme ribonucleoside diphosphate reductase in situ. Both 5-HP and the seleno analog inhibited the isolated enzyme ribonucleoside diphosphate reductase from the Novikoff rat hepatoma; to achieve 50 per cent inhibition required 3.5 × 10 −6 and 6.8 × 10 −6 M respectively. Metal/ ligand ratios and the association constants for these ligands with cobalt and copper were determined. The cobalt/ligand ratio for 5-HP and its seleno analog was 1:2 and the copper/ ligand ratio for these agents was 1:1. Metal/ligand ratios for the guanylhydrazone and semicarbazone derivatives were 1:3 for cobalt and 1:2 for copper. Association constants for 5-HP and the seleno derivative with cobalt were 56 × 10 9 and 7.6 × 10 9 respectively. The findings demonstrated that 5-HP was the optimum member of this series with respect to antineoplastic potency and that tumor-inhibitory activity correlated with the degree of inhibition of the synthesis of DNA and the capacity for metal binding.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.